Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$2.1B
Avg Funding
$83.5M
Cities
18

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Fort Lee, United States
$100.0M
raised

Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palm Beach Gardens, United States
$15.0M
raised

Aeroclean Technologies develops an interior space air purification technology company.

Jun 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$40.0M
raised

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$4.4M
raised

Medicenna is a clinical stage, privately held, immuno-oncology company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$3.5M
raised

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Leiden, The Netherlands
$59.2M
raised

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$50.0M
raised

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Växjö, Sweden
$1.2M
raised

Arcoma AB manufactures and sells digital radiographic systems to private label distributors and OEM customers.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$100.0M
raised

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$1.4M
raised

BioNxt Solutions mission is to develop and commercialize next-generation pharmaceuticals.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$805.0M
raised

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Surrey, Canada
$1.0M
raised

Freedom from glasses and contact lenses is a goal that is now a reality.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Victoria, Canada
$3.1M
raised

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Austin, United States
$210.0M
raised

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$438K
raised

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$6.1M
raised

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Antonio, United States
$3.2M
raised

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Piscataway, United States
$226.0M
raised

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Silver Spring, United States
$13.3M
raised

Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Reykjavík, Iceland
$165.0M
raised

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$50.0M
raised

Mereo is a new UK-based speciality biopharmaceutical company.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 101 to 125 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked